The risk of breast cancer associated with hormone replacement therapy in postmenopausal women is greater than previously thought and is seen after just a year of use, according to a new study. Published in The Lancet, the analysis of combined data from 58 studies involving more than 108,000 postmenopausal women with invasive breast cancer found ...
ER-positive breast cancer risk in HRT users greater than previously thought
By Michael Woodhead
4 Sep 2019